oxazoles has been researched along with pyrophosphate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hillson, NJ; Walsh, CT | 1 |
Abe, I; Asakawa, Y; Awakawa, T; Egami, Y; Ito, T; Kenmoku, H; Mori, T; Nakashima, Y; Piel, J; Wakimoto, T; Wakimoto, Y | 1 |
Balskus, EP | 1 |
Abe, I; Egami, Y; Wakimoto, T | 1 |
Hussar, DA | 1 |
5 other study(ies) available for oxazoles and pyrophosphate
Article | Year |
---|---|
Dimeric structure of the six-domain VibF subunit of vibriobactin synthetase: mutant domain activity regain and ultracentrifugation studies.
Topics: Acylation; Adenosine Triphosphate; Bacterial Proteins; Catalysis; Catechols; Chromatography, Gel; Dimerization; Diphosphates; Enzyme Activation; Genetic Complementation Test; Oxazoles; Peptide Synthases; Protein Structure, Tertiary; Protein Subunits; Sequence Deletion; Time Factors; Titrimetry; Ultracentrifugation | 2003 |
Calyculin biogenesis from a pyrophosphate protoxin produced by a sponge symbiont.
Topics: Animals; Antineoplastic Agents; Diphosphates; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Leukemia; Marine Toxins; Metagenome; Mice; Molecular Sequence Data; Multigene Family; Organophosphates; Oxazoles; Phosphorylation; Phosphotransferases; Phylogeny; Polyketide Synthases; Porifera; RNA, Ribosomal, 16S; Symbiosis | 2014 |
Natural products: Sponge symbionts play defense.
Topics: Animals; Diphosphates; Humans; Marine Toxins; Oxazoles; Porifera | 2014 |
Phosphocalyculin C as a pyrophosphate protoxin of calyculin C in the marine sponge Discodermia calyx.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cytotoxins; Diphosphates; Dose-Response Relationship, Drug; Marine Toxins; Mice; Oxazoles; Porifera | 2014 |
New drugs 2015, part 2.
Topics: Antibodies, Monoclonal, Humanized; Benzhydryl Compounds; Benzofurans; Cyclopropanes; Diphosphates; Drug Approval; Drug Therapy; Glucagon-Like Peptide 1; Glucosides; Glycopeptides; Humans; Lactones; Lipoglycopeptides; Organophosphates; Oxazoles; Pyridines; Sulfates; Teicoplanin; United States; United States Food and Drug Administration | 2015 |